scholarly journals Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART)

2009 ◽  
Vol 14 (2) ◽  
pp. 59 ◽  
Author(s):  
J Teichmann ◽  
U Lange ◽  
T Discher ◽  
J Lohmeyer ◽  
H Stracke ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Human Immunodeficiency Virus ◽  
Antiretroviral Therapy ◽  
Bone Mineral ◽  
Highly Active Antiretroviral Therapy ◽  
Mineral Density ◽  
Highly Active ◽  
Immunodeficiency Virus ◽  
Human Immunodeficiency Virus 1

scholarly journals Prevalence of low bone mineral density in Human Immunodeficiency Virus-infected patients and its correlation with other determinants

2021 ◽  
pp. 36-40
Author(s):  
Swati Mahajan ◽  
Rajiv Raina ◽  
Anupam Jhobta
Keyword(s):  
Bone Mineral Density ◽  
Human Immunodeficiency Virus ◽  
Bone Mineral ◽  
Highly Active Antiretroviral Therapy ◽  
Tertiary Care ◽  
Cd4 Count ◽  
Lumbosacral Spine ◽  
Mineral Density ◽  
Low Bone Mineral Density ◽  
Immunodeficiency Virus

Background: The patients infected with human immunodeficiency virus (HIV) are potentially at risk of low bone mineral density (BMD). The present study was done to find out the prevalence of low BMD in HIV-infected patients and its correlation with other factors such as gender, body mass index (BMI), CD4 count, and highly active antiretroviral therapy (HAART). Methods: This was an observational cross-sectional study conducted in a tertiary care center for 1 year period. A total of 127 HIV-infected patients were evaluated for BMD by dual-energy X-ray absorptiometry (DEXA) scans at two sites lumbosacral spine and bilateral neck femur. Correlation with other factors was also studied. Results: The diagnosis of low BMD was established in 105 (82.67%) patients. Osteoporosis (44.1%) was more common than osteopenia (38.6%) at the lumbosacral spine. The mean T score of the DEXA lumbar spine and bilateral neck femur was observed to be ?2.113 and ?1.379, respectively. Males (88.73%) had low BMD than females (75%). Approximately 94.5% of subjects having BMI <18 had low BMD in contrast to 80.8% among subjects having BMI >18. After treatment, 47 patients had CD4 count <400 and 80 > 400. Forty-three patients out of 47 (91.5%) had low BMD and 62 out of 80 (77.5%) had low BMD. Conclusion: Low BMD is prevalent in HIV-infected subjects. Low BMI, persistently low CD4 count, tenofovir containing HAART regimen showed a positive correlation with low BMD. Hence, HIV infection should be considered as a risk factor for bone disease.

Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy

2006 ◽  
Vol 65 (2) ◽  
pp. 191-197 ◽  
Author(s):  
Mark J. Bolland ◽  
Andrew B. Grey ◽  
Anne M. Horne ◽  
Simon E. Briggs ◽  
Mark G. Thomas ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Antiretroviral Therapy ◽  
Bone Mineral ◽  
Highly Active Antiretroviral Therapy ◽  
Mineral Density ◽  
Highly Active ◽  
Caucasian Men
Sign in / Sign up

Export Citation Format

Share Document